Literature DB >> 21845401

Transforming growth factor-β signaling in tumor initiation, progression and therapy in breast cancer: an update.

Xuyu Zu1, Qinghai Zhang, Renxian Cao, Jianghua Liu, Jing Zhong, Gebo Wen, Deliang Cao.   

Abstract

Transforming growth factor-β (TGF-β) is a ubiquitous cytokine playing an essential role in cell proliferation, differentiation, apoptosis, adhesion and invasion, as well as in cellular microenvironment. In malignant diseases, TGF-β signaling features a growth inhibitory effect at an early stage but aggressive oncogenic activity at the advanced malignant state. Here, we update the current understanding of TGF-β signaling in cancer development and progression with a focus on breast cancer. We also review the current approaches of TGF-β signaling-targeted therapeutics for human malignancies.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21845401     DOI: 10.1007/s00441-011-1225-3

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  25 in total

1.  An essential role for p38 MAPK in cerebellar granule neuron precursor proliferation.

Authors:  Cemile G Guldal; Adiba Ahmad; Andrey Korshunov; Massimo Squatrito; Aashir Awan; Lori A Mainwaring; Bipin Bhatia; Susana R Parathath; Zaher Nahle; Stefan Pfister; Anna M Kenney
Journal:  Acta Neuropathol       Date:  2012-04       Impact factor: 17.088

Review 2.  The role of cytokines in breast cancer development and progression.

Authors:  Marcela Esquivel-Velázquez; Pedro Ostoa-Saloma; Margarita Isabel Palacios-Arreola; Karen E Nava-Castro; Julieta Ivonne Castro; Jorge Morales-Montor
Journal:  J Interferon Cytokine Res       Date:  2014-07-28       Impact factor: 2.607

Review 3.  Targeting TGF-β signaling in cancer.

Authors:  Lior H Katz; Ying Li; Jiun-Sheng Chen; Nina M Muñoz; Avijit Majumdar; Jian Chen; Lopa Mishra
Journal:  Expert Opin Ther Targets       Date:  2013-05-07       Impact factor: 6.902

4.  CCL2 is critical for immunosuppression to promote cancer metastasis.

Authors:  Chie Kudo-Saito; Hiromi Shirako; Misa Ohike; Nobuo Tsukamoto; Yutaka Kawakami
Journal:  Clin Exp Metastasis       Date:  2012-11-11       Impact factor: 5.150

5.  HOXB7 promotes malignant progression by activating the TGFβ signaling pathway.

Authors:  Shou Liu; Kideok Jin; Yvonne Hui; Jie Fu; Chunfa Jie; Sheng Feng; David Reisman; Qian Wang; Daping Fan; Saraswati Sukumar; Hexin Chen
Journal:  Cancer Res       Date:  2014-12-26       Impact factor: 12.701

6.  The correlation between morphology and the expression of TGF-β signaling pathway proteins and epithelial-mesenchymal transition-related proteins in synovial sarcomas.

Authors:  Yan Qi; Cui-Cui Wang; Yong-Lai He; Hong Zou; Chun-Xia Liu; Li-Juan Pang; Jian-Ming Hu; Jin-Fang Jiang; Wen-Jie Zhang; Feng Li
Journal:  Int J Clin Exp Pathol       Date:  2013-11-15

7.  Associations between genetic variants in the TGF-β signaling pathway and breast cancer risk among Hispanic and non-Hispanic white women.

Authors:  Stephanie D Boone; Kathy B Baumgartner; Richard N Baumgartner; Avonne E Connor; Christina M Pinkston; Esther M John; Lisa M Hines; Mariana C Stern; Anna R Giuliano; Gabriela Torres-Mejia; Guy N Brock; Frank D Groves; Richard A Kerber; Roger K Wolff; Martha L Slattery
Journal:  Breast Cancer Res Treat       Date:  2013-09-14       Impact factor: 4.872

8.  Fibulin-3 is a novel TGF-β pathway inhibitor in the breast cancer microenvironment.

Authors:  H Tian; J Liu; J Chen; M L Gatza; G C Blobe
Journal:  Oncogene       Date:  2015-03-30       Impact factor: 9.867

9.  GDF5 regulates TGFß-dependent angiogenesis in breast carcinoma MCF-7 cells: in vitro and in vivo control by anti-TGFß peptides.

Authors:  Francesca Margheri; Nicola Schiavone; Laura Papucci; Lucia Magnelli; Simona Serratì; Anastasia Chillà; Anna Laurenzana; Francesca Bianchini; Lido Calorini; Eugenio Torre; Javier Dotor; Esperanza Feijoo; Gabriella Fibbi; Mario Del Rosso
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

10.  TGF-β Negatively Regulates CXCL1 Chemokine Expression in Mammary Fibroblasts through Enhancement of Smad2/3 and Suppression of HGF/c-Met Signaling Mechanisms.

Authors:  Wei Bin Fang; Benford Mafuvadze; Min Yao; An Zou; Mike Portsche; Nikki Cheng
Journal:  PLoS One       Date:  2015-08-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.